VEGFA and lung carcinoma: HA synthesis inhibition, for example, with 4-methylumbelliferone (4-MU), can dampen oncogenic signaling in several cancers [49], suggesting a potentially unexplored crosstalk with the nicotine–PKA–VEGF axis in lung cancer.